Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR
Author:
Funder
Department of Oncology, Asan Medical Center, Seoul, Korea
Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea
Publisher
Elsevier BV
Subject
Cell Biology
Reference39 articles.
1. Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer;Engelman;Clin. Cancer Res.,2008
2. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib;Kobayashi;N. Engl. J. Med.,2005
3. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain;Pao;PLoS Med.,2005
4. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib;Kwak;Proc. Nat. Acad. Sci. U.S.A.,2005
5. An irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib;Engelman;Cancer Res.,2007
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Induction of resistance to neurotrophic tropomyosin‐receptor kinase inhibitors by HMGCS2 via a mevalonate pathway;Cancer Medicine;2024-06
2. Lung cancer, comorbidities, and medication: the infernal trio;Frontiers in Pharmacology;2024-02-21
3. EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth;Cancer Discovery;2024-01-25
4. New insights into the therapeutic potentials of statins in cancer;Frontiers in Pharmacology;2023-07-07
5. Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing;BMC Bioinformatics;2023-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3